4Nicolai H,Brickl R,Eschey H,et al.Duration of action and Pharmacokinetics of the oral antidiahetic drug gliquidone in patients with non-insulin-dependent (type2) diabetes mellitus.Arzneimittelforschung,1997; 47(3):247-252.
5Guyatt GH,Rennie D,Editors,The Evidence-Based Medicine Working Group.Users' Guides to the Medical Literature:A Manual for Evidence-Based Clinical Practice.AMA Press,Chicago,2002.
6Ciccarone A,Cecchetti P,Orsini P,et al.Effects of gliquidone and glibenclamide on metabolic response and insulin receptor interaction in monocytes from patients with type 2 diabetes mellitus.Current Therapeutic Research,Clinical & Experimental,1999; 60(6):314-325.
7Harrower AD.Comparison of efficacy,secondary failure rate,and complications of sulfonylureas.J Diabetes Complications,1994;8(4):201-203
8Harrower AD.Efficacy of gliclazide in comparison with other sulphonylureas in the treatment of NIDDM.Diabetes research and clinicalpractice,1991; 14(2):s65-67.
9Harrower AD.Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas.Curr MedRes Opin,1985; 9(10):676-680.
10Nikkil K,Groop L.Glibenclamide and gliquidone in the treatment of non-insulin-dependent diabetes mellitus.Acta medica Scandinavica,1982; 211(1-2):13-17.
